SCHEMBL28029841

SCHEMBL28029841

CCN1CCN(C(=O)c2cccc(Nc3nccc(-c4ccc(N5CCCC5)c(C#N)c4)n3)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TBK1 Q9UHD2 2/20 0.56
▸ MTOR P42345 1/20 0.49
▸ SMG1 Q96Q15 1/20 0.49
▸ STK17A Q9UEE5 1/20 0.48
▸ DYRK2 Q92630 1/20 0.48
▸ SYK P43405 1/20 0.48
▸ JAK2 O60674 5/20 0.47
▸ JAK3 P52333 3/20 0.47
▸ NTRK1 P04629 1/20 0.46
▸ CSNK2A1 P68400 1/20 0.45
▸ CCNT1 O60563 3/20 0.44
▸ CDK1 P06493 3/20 0.44
▸ CCNB1 P14635 3/20 0.44
▸ CCNA2 P20248 3/20 0.44
▸ CDK2 P24941 3/20 0.44
▸ CDK7 P50613 3/20 0.44
▸ CDK9 P50750 3/20 0.44
▸ CCNH P51946 3/20 0.44
▸ PARP1 P09874 1/20 0.43
▸ PARP2 Q9UGN5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10080358 0.91 TBK1 (0.58) TBK1MTORSMG1STK17ASYK
SCHEMBL434437 0.85 TBK1 (0.61) TBK1MTORSMG1STK17ASYK
SCHEMBL10081571 0.85 ABL1 (0.59) TBK1MTORSMG1STK17AJAK2
SCHEMBL431866 0.84 TBK1 (0.61) TBK1MTORSMG1STK17ASYK
SCHEMBL432527 0.81 JAK2 (0.65) TBK1MTORSMG1STK17AJAK2
SCHEMBL432714 0.81 CDC7 (0.59) TBK1STK17AJAK2JAK3CSNK2A1
SCHEMBL460899 0.81 TBK1 (0.60) TBK1MTORSMG1STK17AJAK2
SCHEMBL29932219 0.81 TBK1 (0.60) TBK1MTORSMG1STK17AJAK2
SCHEMBL4378275 0.81 JAK2 (0.61) MTORSMG1DYRK2SYKJAK2
SCHEMBL432429 0.79 CDK2 (0.57) TBK1STK17AJAK2JAK3NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103119025-B Pyrimidine compounds as inhibitors of protein kinase IKK and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them DOMAINEX LTD. (GB) 2015-09-09 — — CN disclosed
Send feedback